Eli Lilly and Company
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Eli Lilly and Company (LLY) SEC Filings
Browse all Eli Lilly and Company SEC filings, including Annual reports (10-K), Quarterly reports (10-Q), 8-K, proxy statements (DEF 14A), and insider filings (Form 4). Access official documents by filing date, reporting period, and form type. ...more
Eli Lilly and Company Reports: Annual 10-K, Quarterly 10-Q & SEC Filings
SEC Filings
Date
2026
DFAN14A
Additional proxy materials filed by non-management parties
SC 13G/A
Updated passive ownership disclosure
DEFA14A
Additional or supplemental proxy disclosures
DEF 14A
Final shareholder voting details (board elections and executive pay)
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
PRE 14A
Preliminary proxy statement filed for SEC review
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4/A
Correction to a previously reported insider transaction
10-K
Annual financial results and management updates
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
8-K
Material company events (earnings, M&A, or leadership changes)
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
Eli Lilly and Company (Form DFAN14A) 2026
Proxy & Voting / Additional proxy materials filed by non-management parties
Mar 31, 2026
